Rossi V - Search Results

1

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives.

Roviello G, Catalano M, Santi R, Palmieri VE, Vannini G, Galli IC, Buttitta E, Villari D, Rossi V, Nesi G. Roviello G, et al. Among authors: rossi v. Cancers (Basel). 2021 Aug 31;13(17):4411. doi: 10.3390/cancers13174411. Cancers (Basel). 2021. PMID: 34503220 Free PMC article. Review.

2

Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.

Paderi A, Giorgione R, Giommoni E, Mela MM, Rossi V, Doni L, Minervini A, Carini M, Pillozzi S, Antonuzzo L. Paderi A, et al. Among authors: rossi v. Cancers (Basel). 2021 Feb 18;13(4):860. doi: 10.3390/cancers13040860. Cancers (Basel). 2021. PMID: 33670634 Free PMC article.

3

Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice.

Roviello G, Catalano M, Ottanelli C, Giorgione R, Rossi V, Gambale E, Casadei C, De Giorgi U, Antonuzzo L. Roviello G, et al. Among authors: rossi v. Med Oncol. 2022 Jul 14;39(10):145. doi: 10.1007/s12032-022-01739-3. Med Oncol. 2022. PMID: 35834026 Review.

4

Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer.

Caliman E, Petrella MC, Rossi V, Mazzoni F, Grosso AM, Fancelli S, Paglialunga L, Comin C, Roviello G, Pillozzi S, Antonuzzo L. Caliman E, et al. Among authors: rossi v. Curr Cancer Drug Targets. 2022 Aug 31. doi: 10.2174/1568009622666220831142452. Online ahead of print. Curr Cancer Drug Targets. 2022. PMID: 36045535

5

Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival.

Gambale E, Palmieri VE, Rossi V, Francini E, Bonato A, Salfi A, Galli L, Mela MM, Pillozzi S, Antonuzzo L. Gambale E, et al. Among authors: rossi v. Cancer Diagn Progn. 2023 Sep 3;3(5):538-542. doi: 10.21873/cdp.10252. eCollection 2023 Sep-Oct. Cancer Diagn Progn. 2023. PMID: 37671314 Free PMC article.

6

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Maiorano BA, Di Maio M, Cerbone L, Maiello E, Procopio G, Roviello G; MeetURO Group. Maiorano BA, et al. JAMA Netw Open. 2024 Mar 4;7(3):e241215. doi: 10.1001/jamanetworkopen.2024.1215. JAMA Netw Open. 2024. PMID: 38446479 Free PMC article.

7

Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer.

DI Maida F, Grosso AA, Tellini R, Lambertini L, Lo Re M, Cadenar A, Giudici S, Giorgione R, Rossi V, Antonuzzo L, Minervini A, Mari A. DI Maida F, et al. Among authors: rossi v. Minerva Urol Nephrol. 2022 Oct;74(5):642-646. doi: 10.23736/S2724-6051.22.04959-X. Minerva Urol Nephrol. 2022. PMID: 36125025 Free article. No abstract available.

8

Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes.

Tibaldi C, Mazzoni F, Scotti V, Vasile E, Pozzessere D, Stasi I, Camerini A, Federici F, Meoni G, Caparello C, Turrini M, Rossi V, Ciccone LP, Pecora I, Fantechi B, Antonuzzo L, Giannarelli D, Baldini E. Tibaldi C, et al. Among authors: rossi v. Anticancer Agents Med Chem. 2022;22(7):1278-1285. doi: 10.2174/1871520621666210727112212. Anticancer Agents Med Chem. 2022. PMID: 34315390

9

A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy.

Hasic Telalovic J, Pillozzi S, Fabbri R, Laffi A, Lavacchi D, Rossi V, Dreoni L, Spada F, Fazio N, Amedei A, Iadanza E, Antonuzzo L. Hasic Telalovic J, et al. Among authors: rossi v. Diagnostics (Basel). 2021 Apr 28;11(5):804. doi: 10.3390/diagnostics11050804. Diagnostics (Basel). 2021. PMID: 33925256 Free PMC article.

10

Alternative approaches to the prognostic stratification of mild to moderate primary vesicoureteral reflux in children.

Sciagrà R, Materassi M, Rossi V, Ienuso R, Danti A, La Cava G. Sciagrà R, et al. Among authors: rossi v. J Urol. 1996 Jun;155(6):2052-5; discussion 2055-6. J Urol. 1996. PMID: 8618333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

907 results

Search Page